They should treat connected medical devices as continuously governed assets, not finished products. That means maintaining inventory, monitoring for exploitable weaknesses, prioritising updates by patient impact, and assigning clear ownership for postmarket remediation. In healthcare, the governance model has to cover the entire device lifecycle, because the safety risk does not end at release.
Why This Matters for Security Teams
Connected medical devices are not static endpoints once they leave the factory. They remain safety-critical, remotely reachable, and often dependent on software, credentials, and vendor services that age over time. That makes post-deployment governance a patient safety issue, not just an IT hygiene issue. NIST’s Cybersecurity Framework 2.0 is useful here because it reinforces continuous identify-protect-detect-respond-recover discipline, while NHI Mgmt Group’s Lifecycle Processes for Managing NHIs shows why inventory, ownership, rotation, and offboarding must continue after deployment.
The most common mistake is treating device certification as a finish line. In reality, device access paths, embedded secrets, remote service accounts, and third-party dependencies can become attack pathways long after installation. The governance question is therefore not “is the device approved?” but “who owns it, how is it monitored, and how quickly can risk be reduced when conditions change?” In practice, many security teams encounter compromised device credentials only after unusual network activity, vendor support abuse, or delayed patching has already affected care.
How It Works in Practice
Effective post-deployment governance starts with a living inventory that includes model, firmware, software version, connectivity paths, owner, vendor, clinical criticality, and update support status. That inventory should feed risk decisions, because a device supporting life-sustaining therapy cannot be handled the same way as a low-acuity monitor. Postmarket controls should also track embedded secrets, remote access channels, and any non-human identities the device uses to authenticate to hospital systems or cloud services.
Security teams should pair that inventory with ongoing monitoring and a clear remediation path. The most practical pattern is:
- Classify devices by patient impact and operational dependency.
- Track vulnerabilities against active exposure, not just published severity.
- Prioritise updates when the device is internet-facing, remotely managed, or part of a high-risk clinical workflow.
- Require named ownership for patch approval, compensating controls, and vendor escalation.
- Revoke or rotate credentials when a device is retired, reassigned, or no longer supported.
For governance language and lifecycle framing, NHI Mgmt Group’s Top 10 NHI Issues is especially relevant because unmanaged secrets, excessive privilege, and weak rotation are recurring failure modes in connected environments. Security teams should also align device governance to the NIST Cybersecurity Framework 2.0 so that postmarket remediation is treated as an ongoing operational control, not an ad hoc service desk task. These controls tend to break down when devices are vendor-managed but hospital-owned, because accountability becomes split across clinical engineering, IT, and the supplier.
Common Variations and Edge Cases
Tighter device governance often increases operational overhead, requiring organisations to balance patient safety against downtime, staffing, and vendor response limits. That tradeoff is real in clinical settings where patch windows are narrow, validation is slow, and some devices cannot be updated without vendor intervention. Current guidance suggests documenting the risk acceptance process rather than assuming every vulnerability can be fixed immediately.
There is no universal standard for every medical device scenario, but a few edge cases matter. Legacy devices may be impossible to patch, which makes compensating controls such as segmentation, protocol restriction, and monitored jump access more important. Cloud-connected and telehealth-linked devices may also introduce external NHI dependencies that need the same lifecycle discipline as internal systems. Procurement and postmarket operations should therefore be linked, since unsupported devices and unowned credentials become long-term liabilities. NHI Mgmt Group’s Regulatory and Audit Perspectives is useful for showing how lifecycle evidence, ownership, and revocation controls support both assurance and accountability.
Best practice is evolving toward continuous, risk-based governance rather than one-time compliance checks. Security teams that rely on annual reviews usually miss the moment when a vendor account, embedded token, or unsupported firmware version turns a managed device into an unmanaged exposure.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Non-Human Identity Top 10 address the attack and risk surface, while NIST CSF 2.0 and NIST CSF 2.0 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | ID.AM-1 | Asset inventory is central to governing deployed medical devices. |
| NIST CSF 2.0 | PR.PT-3 | Protective technology supports segmentation and access restriction for devices. |
| OWASP Non-Human Identity Top 10 | NHI-03 | Credential rotation and revocation are key for embedded device identities. |
Rotate device secrets routinely and revoke them when devices are retired or reassigned.
Related resources from NHI Mgmt Group
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on June 25, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
